Radiotherapy for Bone Metastases in Patients With Excellent Performance Status: Patterns of Care and Prognostic Factors for Survival
Many patients with ECOG PS 0 experience long-term survival, influenced by disease behavior and choice of fractionation, among others. The impact of fractionation was due to imbalances in baseline characteristics, <i>e.g.</i>, proportion of patients with de novo hormone-sensitive prostate cancer with low-volume disease receiving fractionated radiotherapy to both prostate and bone metastases. No clear impact of equivalent radiation dose in 2-Gy fractions on survival emerged.
Authors
- Bård Mannsåker (ORCID: https://orcid.org/0009-0007-6730-5473)
- Ellinor Haukland (ORCID: https://orcid.org/0000-0002-5697-2218)
- Carsten Nieder (ORCID: https://orcid.org/0000-0003-1592-2908)
- Luka Stanisavljević
Institutions
- Nordland Hospital Trust (NO)
- UiT The Arctic University of Norway (NO)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.21873/anticanres.17502
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00